[go: up one dir, main page]

RU2008131621A - APPLICATION OF MADOPAR FOR CORRECTION OF COGNITIVE, MOTIVATIONAL, EMOTIONAL DISORDERS IN CHILDREN WITH AUTISTIC DISORDERS - Google Patents

APPLICATION OF MADOPAR FOR CORRECTION OF COGNITIVE, MOTIVATIONAL, EMOTIONAL DISORDERS IN CHILDREN WITH AUTISTIC DISORDERS Download PDF

Info

Publication number
RU2008131621A
RU2008131621A RU2008131621/15A RU2008131621A RU2008131621A RU 2008131621 A RU2008131621 A RU 2008131621A RU 2008131621/15 A RU2008131621/15 A RU 2008131621/15A RU 2008131621 A RU2008131621 A RU 2008131621A RU 2008131621 A RU2008131621 A RU 2008131621A
Authority
RU
Russia
Prior art keywords
disorders
madopar
motivational
cognitive
children
Prior art date
Application number
RU2008131621/15A
Other languages
Russian (ru)
Other versions
RU2403034C2 (en
Inventor
Татьяна Евгеньевна Старовойтова (RU)
Татьяна Евгеньевна Старовойтова
Владимир Валентинович Долгих (RU)
Владимир Валентинович Долгих
Татьяна Анатольевна Тетерина (RU)
Татьяна Анатольевна Тетерина
Ванда Иосифовна Михнович (RU)
Ванда Иосифовна Михнович
Владимир Матвеевич Поляков (RU)
Владимир Матвеевич Поляков
Ольга Николаевна Протопопова (RU)
Ольга Николаевна Протопопова
Татьяна Альбертовна Белогорова (RU)
Татьяна Альбертовна Белогорова
Original Assignee
Государственное учреждение Научный центр медицинской экологии Восточно-Сибирского научного центра Сибирского отделения Российской а
Государственное учреждение Научный центр медицинской экологии Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное учреждение Научный центр медицинской экологии Восточно-Сибирского научного центра Сибирского отделения Российской а, Государственное учреждение Научный центр медицинской экологии Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук filed Critical Государственное учреждение Научный центр медицинской экологии Восточно-Сибирского научного центра Сибирского отделения Российской а
Priority to RU2008131621/15A priority Critical patent/RU2403034C2/en
Publication of RU2008131621A publication Critical patent/RU2008131621A/en
Application granted granted Critical
Publication of RU2403034C2 publication Critical patent/RU2403034C2/en

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Применение мадопара в качестве лекарственного препарата для коррекции когнитивных, мотивационных, эмоциональных нарушений у детей с аутистическими расстройствами. The use of madopar as a drug for the correction of cognitive, motivational, emotional disorders in children with autistic disorders.

Claims (1)

Применение мадопара в качестве лекарственного препарата для коррекции когнитивных, мотивационных, эмоциональных нарушений у детей с аутистическими расстройствами. The use of madopar as a drug for the correction of cognitive, motivational, emotional disorders in children with autistic disorders.
RU2008131621/15A 2008-07-30 2008-07-30 Application of madopar for correction of cognitive, motivation, emotional disturbances in children with autistic spectrum disorders RU2403034C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2008131621/15A RU2403034C2 (en) 2008-07-30 2008-07-30 Application of madopar for correction of cognitive, motivation, emotional disturbances in children with autistic spectrum disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2008131621/15A RU2403034C2 (en) 2008-07-30 2008-07-30 Application of madopar for correction of cognitive, motivation, emotional disturbances in children with autistic spectrum disorders

Publications (2)

Publication Number Publication Date
RU2008131621A true RU2008131621A (en) 2010-04-10
RU2403034C2 RU2403034C2 (en) 2010-11-10

Family

ID=42670739

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008131621/15A RU2403034C2 (en) 2008-07-30 2008-07-30 Application of madopar for correction of cognitive, motivation, emotional disturbances in children with autistic spectrum disorders

Country Status (1)

Country Link
RU (1) RU2403034C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2666598C1 (en) * 2017-07-14 2018-09-11 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" Agent for correcting autism spectrum disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2253461C1 (en) * 2004-04-30 2005-06-10 Общество с ограниченной ответственностью "Паркинфарм" Pharmaceutical combination influencing central nervous system function; method of correcting conditions associated with dysfunction of central nervous system; pharmaceutical kit; agent assisting therapeutical substances and metabolites to cross blood-brain barrier; and endonasal drug

Also Published As

Publication number Publication date
RU2403034C2 (en) 2010-11-10

Similar Documents

Publication Publication Date Title
EA201001402A1 (en) PHARMACEUTICAL SOLUTIONS, METHOD FOR OBTAINING AND THERAPEUTIC APPLICATION
EA201170465A1 (en) METHODS OF TREATMENT OF PROGRESSIVE MULTIPLE SCLEROSIS
CL2013000261A1 (en) Compounds derived from nitrogen heterocycles, with ampk activity; pharmaceutical composition; in vitro methods; and its use in cardiovascular diseases, type II diabetes, muscular dystrophy, neurological disorders, inflammatory diseases, among others.
CY1120741T1 (en) TREATMENT OF NOSE SCRUB
CL2015001358A1 (en) Enhanced cftr enhancers
CL2008001994A1 (en) COMPOUNDS DERIVED FROM PIRAZIN-2-ONA; PHARMACEUTICAL COMBINATION; AND USE IN THE TREATMENT OF DISEASES SUCH AS DIABETES, ATEROSCLEROSIS, HYPERTENSION, AMONG OTHERS.
PT2280721T (en) IMMUNE THERAPY BASED ON INDOLEAMINE 2,3-DIOXYGENASE
IL211400A0 (en) Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
CL2009000990A1 (en) Use of epothilone d for the treatment of diseases associated with tau, such as Alzheimer's disease, Parkinson's, among others.
PL3133396T3 (en) METHOD OF TREATMENT WITH THE USE OF DRUGS FOR AMMONIA
IT1395519B1 (en) COMPOSITE PIECE, AS WELL AS THE USE OF THE COMPOSITE PIECE
AR061446A1 (en) USE OF 1,7-DIMETHYLXANTINE FOR THE MANUFACTURE OF A NON-ANIOIOUS PSYCHOANALEPTIC DRUG FOR THE TREATMENT OF A NEUROPSYCHIATRIC DISORDER
EA201200484A1 (en) PHARMACEUTICAL COMPOSITION WITH EXISTING SUBSTANCES - METHORMIN AND SYTAGLIPTIN OR VILDAGLIPTIN
CO6241120A2 (en) (DIHIDRO) PIRROLO [2,1-á] ISOQUINOLINAS.
CY1114880T1 (en) MGLU2 AGONISTS
EA201491300A1 (en) COMPOSITION FOR BODY APPLICATION WITH IMPROVED STABILITY
ATE531715T1 (en) 1,3-DIHYDRO-2H-PYRROLOÄ3.2-BÜPYRIDINE-2-ONDERIVA E, THEIR PRODUCTION AND THEIR THERAPEUTIC USES
CL2008001837A1 (en) Use of compounds derived from cinolin-3-carboxamide in the treatment of schizophrenia.
CL2009000257A1 (en) Use of 1,3-substituted imidazolines and their physiologically compatible salts for the treatment of metabolic syndrome.
BR112013007369A2 (en) multi-segment linear meniscus wall lens
RU2008131621A (en) APPLICATION OF MADOPAR FOR CORRECTION OF COGNITIVE, MOTIVATIONAL, EMOTIONAL DISORDERS IN CHILDREN WITH AUTISTIC DISORDERS
EA201071203A1 (en) DRONEDARON COMBINATION AT LEAST WITH ONE DIURETIC, ITS USE IN THERAPY
RU2008136668A (en) PEPTIDES WITH NEUROTROPIC ACTIVITY
RU2010146152A (en) MEDICINE WITH CARDIOPROTECTIVE ACTIVITY
IT1397456B1 (en) LAMP FOR EMERGENCY LIGHTING WITH UNIFORM LIGHTING.

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20130731